Nature Biotechnology

Journal

Publication Venue For

  • Good laboratory practice for clinical next-generation sequencing informatics pipelines.  33:689-693. 2015
  • An interdisciplinary shift in demand for talent within the biotech industry.  31:853-855. 2013
  • Genome interpretation and assembly-recent progress and next steps..  30:1081-1083. 2012
  • Reading DNA at single-nucleotide resolution with a mutant MspA nanopore and phi29 DNA polymerase.  30:349-353. 2012
  • Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells.  29:1117-1119. 2011
  • A roadmap for biomarker qualification.  28:444-445. 2010
  • An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer.  27:1005-1011. 2009
  • An integrated software system for analyzing ChIP-chip and ChIP-seq data.  26:1293-1300. 2008
  • Probabilistic model of the human protein-protein interaction network.  23:951-959. 2005
  • Embryonic stem cells pace the heart.  22:1237-1238. 2004
  • Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo.  19:838-842. 2001
  • Cytokine production in motor neurons by poliovirus replicon vector gene delivery.  18:964-969. 2000
  • A system for the propagation of adenoviral vectors with genetically modified receptor specificities.  17:470-475. 1999
  • Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand - Producing antigen presenting cells.  16:1045-1049. 1998
  • Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector.  15:866-870. 1997
  • Chaos in the heart: Implications for clinical cardiology.  8:1018-1024. 1990
  • Chaos in the heart: Implications for clinical cardiology.  8:1018-1024. 1990

    • International Standard Serial Number (issn)

  • 0733-222X
  • 1087-0156

    • Electronic International Standard Serial Number (eissn)

  • 1546-1696